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Abstract
The content of mobile genetic elements in Pseudomonas aeruginosa
isolates of a pristine natural mineral water system associated with
healthcare was compared with clinical isolates from respiratory
infections. One isolate, from the therapy pool circuit, presented a
class 1 integron, with 100% similarity to a class 1 integron
contained in plasmid p4800 of the Klebsiella pneumoniae Kp4800
strain, which is the ﬁrst time it has been reported in P. aeruginosa.
Class 1 integrons were found in 25.6% of the clinical isolates.
PAGI1 orf3 was more prevalent in environmental isolates, while
PAGI2 c105 and PAGI3 sg100 were more prevalent in clinical
isolates. Plasmids were not observed in either population.
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Pseudomonas aeruginosa is known for its environmental ubiquity
and its ability to cause several infections in immunocompro-
mised humans, with a high impact on morbidity and mortality.
Ten per cent of its genome is ﬂexible, and limited to speciﬁc
chromosomal locations referred to as genomic islands (GEIs).
PAGI (P. aeruginosa genomic island) 1 was the ﬁrst GEI
described in P. aeruginosa, in an isolate from a urinary infection
sample, and is present in about 85% of all clinical isolates. PAGI2
was ﬁrst described in a cystic ﬁbrosis patient and PAGI3 in an
aquatic isolate. PAGI4 to 11 and PAPI (P. aeruginosa pathogenic
island) 1 and 2 have been reported, but less frequently [1].
Integrons and plasmids are also part of the P. aeruginosa ﬂexible
genome and all are considered mobile genetic elements (MGEs)
[2], contributing to the success of the niche-based adaptation of
the strains and spread of antibiotic resistance genes [3]. Natural
mineral water (NMW) is used in hydrotherapy facilities,
commonly named thermae, to treat mainly respiratory and
rheumatological conditions, considered risk factors for pneu-
monia [4]. Regulations prohibit disinfection of NMW [5], which
may lead to thermae users being exposed to contaminated
NMW during treatment. Some studies report MGEs in P. aeru-
ginosa from water [6–9], but none reports them in NMW from
thermae settings. These facilities are relevant to public health
because they provide medical healthcare treatments.
Ninety non-clonal P. aeruginosa isolates were used: 51
thermae (planktonic and bioﬁlm) isolates and 39 (respiratory
infections) clinical isolates, previously selected by pulsed-ﬁeld
gel electrophoresis (PFGE) (Table 1). All isolates were
screened for plasmid content, class 1, 2 and 3 integrons and
PAGI1, 2 and 3. Conventional plasmids were screened by the
alkaline lysis method [10]. Megaplasmids were detected by
S1-digestion PFGE [11]. Integrons were screened using a
two-step strategy: ﬁrst, screening of intI1, intI2 and intI3
integrases [12], and then integron content screening, with
adequate primers [13]. PAGI1 was screened using orf3, orf18
and orf42 primers, PAGI2 using c22 and c105 primers and
PAGI3 using sg8 and sg100 primers [14]. All positive
PCR-amplicons were sequenced and compared with previ-
ously reported sequences, available in GenBank. Chi-square
tests (95% signiﬁcance level) were used to infer the distribu-
tion of MGEs between populations.
The Pseudomonas aeruginosa ﬂexible genome is important for
it to thrive in diverse environments [1,2], conferring speciﬁc
phenotypes that are advantageous under selective pressure,
particularly drug-resistance and virulence features. Class 1
integron is frequently found in P. aeruginosa clinical isolates,
class 2 is rare and class 3 has not yet been reported [3].
Integrons were not detected in thermae isolates, except in one
isolate from the therapy pool circuit, where contamination by
pool users may occur. The isolate contained a class1-integron
800 bp PCR-amplicon, 100% similar to Klebsiella pneumoniae
strain Kp 4800 plasmid p4800 class 1 integron (EU622041.1),
this being the ﬁrst description in P. aeruginosa (Gen Bank
accession number KF525705) and suggesting horizontal gene
transfer between the two species. Rosser and Young [6]
reported 3.6% class 1 integrons in a 3000 bacterial population
from an estuary. Zanetti et al. [9] reported plasmids and class 1
and 2 integrons in superﬁcial water P. aeruginosa isolates. Both
systems are subjected to pollution, including antibiotics [15], in
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TABLE 1. Description of isolates and respective MGE proﬁle. Isolates were grouped according to presence/absence of MGE and
not taking into account the integron contents of each isolate
Isolate number Type Location Class1 integron
PAG1 PAGI2 PAGI3
MGE typeorf3 orf18 orf42 c22 c105 sg8 sg100
071 Clin – Sput Unit 2 + + +   +  + MGE-1
133 Clin – Sput Neurology  + +   +  + MGE-2
097 Clin – Aspir Outpatient + + +   +   MGE-3
159 Clin – Sput Emergency + + +   +  
182 Clin – Sput Pneumology + + +   +  
198 Clin – Aspir Medicine + + +   +  
F42 NMW Plank Borehole 2  + +   +   MGE-4
C104 NMW Plank Therapy pool  + +   +  
C270 NMW Plank Hydromassage  + +   +  
C331 NMW Plank Nasal Ir./Aerosol  + +   +  
B14 NMW Bioﬁlm Collective nebul.  + +   +  
B15 NMW Bioﬁlm Collective nebul.  + +   +  
B19 NMW Bioﬁlm Collective nebul.  + +   +  
B26 NMW Bioﬁlm Collective nebul.  + +   +  
003 Clin – Aspir ICU  + +   +  
079 Clin – Aspir Medicine  + +   +  
107 Clin – Sput Medicine  + +   +  
111 Clin – Sput Neurology  + +   +  
125 Clin – Aspir ICU  + +   +  
209 Clin – Sput Pneumology  + +   +  
B52 NMW Bioﬁlm Collective nebul.  + +    +  MGE-5
043 Clin – Aspir ICU  + + +     MGE-6
204 Clin – Sput IDU + +    +  + MGE-7
104 Clin – Aspir Pneumology  +    +  + MGE-8
051 Clin – Sput Pneumology + + +      MGE-9
080 Clin – Sput Outpatient + + +     
109 Clin – Aspir Day Care + + +     
F44 NMW Plank Borehole 1  + +      MGE-10
C9 NMW Plank Vichy shower  + +     
C17 NMW Plank Main deposit  + +     
C34 NMW Plank Nasal Ir./Aerosol  + +     
C84 NMW Plank Drinking  + +     
C187 NMW Plank Main deposit  + +     
C230 NMW Plank Hydromassage  + +     
B1 NMW Bioﬁlm Collective nebul.  + +     
B21 NMW Bioﬁlm Aerosol equip.  + +     
B29 NMW Bioﬁlm Aerosol equip.  + +     
B30 NMW Bioﬁlm Aerosol equip.  + +     
B32 NMW Bioﬁlm Collective nebul.  + +     
B75 NMW Bioﬁlm Collective nebul.  + +     
B94 NMW Bioﬁlm Aerosol equip.  + +     
B95 NMW Bioﬁlm Aerosol equip.  + +     
062 Clin – Sput Neuro-surgery  + +     
129 Clin – Sput Neurology  + +     
137 Clin – Aspir Unit 2  + +     
B39 NMW Bioﬁlm Collective nebul.  +   +    MGE-11
B63 NMW Bioﬁlm Collective nebul.  +   +   
095 Clin – Aspir Medicine  +    +   MGE-12
158 Clin – Aspir ICU  +    +  
B110 NMW Bioﬁlm Aerosol equip.  +    +  
B86 NMW Bioﬁlm Aerosol equip.  +     +  MGE-13
B20 NMW Bioﬁlm Collective nebul.   +   +   MGE-14
F1 NMW Plank Borehole 2  +       MGE-15
F14 NMW Plank Borehole 1  +      
F29 NMW Plank Borehole 2  +      
F34 NMW Plank Borehole 2  +      
F49 NMW Plank Borehole 1  +      
F61 NMW Plank Borehole 1  +      
F65 NMW Plank Borehole 2  +      
C1 NMW Plank Nasal Ir./Aerosol  +      
C19 NMW Plank Hydromassage  +      
C30 NMW Plank Therapy pool  +      
C97 NMW Plank Vichy shower  +      
C172 NMW Plank Hydromassage  +      
C176 NMW Plank Pharinx shower  +      
C301 NMW Plank Therapy pool  +      
B12 NMW Bioﬁlm Collective nebul.  +      
B40 NMW Bioﬁlm Collective nebul.  +      
B79 NMW Bioﬁlm Aerosol equip.  +      
B107 NMW Bioﬁlm Collective nebul.  +      
B108 NMW Bioﬁlm Aerosol equip.  +      
214 Clin – Sput Neuro-surgery  +      
115 Clin – Sput Pneumology +  +      MGE-16
012 Clin – Sput Neurology   +      MGE-17
029 Clin – Sput Neurology   +     
058 Clin – Aspir Neuro-surgery   +     
067 Clin – Aspir Medicine   +     
076 Clin – Sput Medicine   +     
135 Clin – Aspir ICU        + MGE-18
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contrast to NMW, wholesome water that cannot suffer any
chemical or microbiological change prior to use [5]. Ten clinical
isolates presented class 1 integrons. The majority contained
aadA11 and half had aadB gene cassettes. Ruiz-Martınez et al.
[8] presented similar results, but aadB was the most frequent
gene cassette, followed by aadA11. Class 2 and 3 integrons and
plasmids were not detected in the present study, as reported in
the literature [3,8].
Regarding GEIs, PAGI1 orf3 and orf18 and PAGI2 c105 were
the only PAGI genes present in both populations and were
those with a higher prevalence (Fig. 1). PAGI1 orf3 was more
prevalent in thermae (p 0.001). PAGI2 c105 (p 0.035) and
PAGI3 sg100 (p 0.013) were more prevalent in clinical isolates.
Several studies report GEIs in strains from human infections
and aquatic habitats [1,7,14,16], consistent with the fact that
some GEIs encoded functions contribute to general adaptabil-
ity and competitiveness rather than exclusively to infection
processes [16], and virulence traits are probably natural
features that bacteria have in order to avoid predation and
survive in soil and water [17,18], which may explain the
presence of GEIs in thermae isolates.
When considering the MGE proﬁle of each isolate, it was
possible to observe that clinical isolates presented higher MGE
diversity (15 MGE-types) and higher content of GEIs per
isolate (MGE-type 1 to 4) than environmental ones (Table 1).
MGE-15 (presence of orf3) was more frequent (22.2%),
followed by MGE-10 (presence of orf3 and orf18) (20%),
both mainly represented by NMW isolates. Clinical isolates
presented higher frequency of isolates with no MGEs (n = 9),
while only two NMW isolates had no MGEs. This is consistent
with a more homogeneous distribution of MGEs, mainly GEIs,
in the NMW environment than in the clinical setting, probably
due to less stressful genetic conditions than those found in the
hospital setting, ﬁlled with antibiotics, antiseptics and disinfec-
tants, which may lead to higher gene mobilization between
strains, as suggested by Ruiz-Martınez et al. [8].
This study has ﬁrst demonstrated the MGE content of
pristine NMW P. aeruginosa isolates, almost exclusively
restricted to GEIs. A class 1 integron, from K. pneumoniae,
was described for the ﬁrst time in P. aeruginosa, from a NMW
therapy pool. This observation, although restricted to one
isolate, is worrying because the integron can spread to other
bacteria and disseminate to the water system. We think it is
important to regularly assess MGEs in thermae facilities, to
better understand possible resistance dissemination in these
healthcare-associated environments.
Acknowledgements
This study was supported by a doctoral fellowship (SFRH/BD/
46668/2008) of the Portuguese Foundation for Science and
Table 1 (Continued)
Isolate number Type Location Class1 integron
PAG1 PAGI2 PAGI3
MGE typeorf3 orf18 orf42 c22 c105 sg8 sg100
C268 NMW Plank Therapy pool +        MGE-19
C101 NMW Plank Therapy pool         MGE-20
B65 NMW Bioﬁlm Collective nebul.        
013 Clin – Sput Neurology        
030 Clin – Sput Neurology        
061 Clin – Sput Neurology        
103 Clin – Sput Neuro-surgery        
127 Clin – Sput IDU        
142 Clin – Sput Neurology        
218 Clin – Aspir IDU        
223 Clin – Sput IDU        
Clin, clinical isolate; Sput, sputum; Aspir, aspirate; NMW, natural mineral water; Plank, planktonic isolate; Bioﬁlm, bioﬁlm isolate; Ir, irrigation; Nebul, nebulizer; ICU, intensive care
unit; IDU, infectious diseases unit; equip, equipment.
FIG. 1. Prevalence (%) of PAGI1 (orf3, orf18 and orf42), PAGI2 (c22
and c105) and PAGI3 (sg8 and sg100) genes in natural mineral water
and clinical isolates.
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